
|Articles|October 1, 2012
Nerve stimulation 'good option' in refractory voiding dysfunction
An implantable neurostimulator (InterStim, Medtronic, Minneapolis) improves voiding outcomes in patients with voiding dysfunction that is refractory to other therapies, a retrospective long-term follow-up of patients at a single center showed.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Toni Choueiri, MD, reacts to FDA approval of adjuvant belzutifan with pembrolizumab for ccRCC
2
Dean Elterman, MD, highlights efficacy and safety data on the Zenflow Prostatic Spring
3
FDA approves capivasertib plus abiraterone and prednisone for PTEN-deficient mHSPC
4
The UroOnc Minute: Variant Histologies in Bladder Cancer, With Carissa Chu, MD
5











